AGP Executive Report
Last update: 2 hours agoMedical Cannabis Access & Delivery: Texas patients in the Compassionate Use Program can now use vaporization products, with same-day access via physician appointments and digital prescriptions. Policy & Road Safety: Australia is moving toward a “medically prescribed THC” driving limit (50 ng/mL in saliva) to avoid penalizing patients who aren’t impaired, while Kentucky lawmakers are pushing to prosecute agencies that back Beshear’s medical cannabis expansion. Research & Regulation: Federal officials are reconsidering marijuana’s Schedule I status, which could reshape research and patient access; meanwhile, a report says rescheduling is prompting changes for research and access. Pain & Product News: Germany approved Exilby, a marijuana-derived oral tincture for chronic pain, aiming to reduce reliance on opioids. State-by-State Market Moves: Florida’s MMJ Health is offering $99 medical marijuana evaluations for new patients through June 2026. Public Health Watch: Europe detected 50 new psychoactive substances in 2025, and cannabis/THC use among youth is rising alongside nicotine co-use. Nutrition for Sleep: New reporting highlights magnesium-rich foods as linked to improved sleep and stress regulation. Safety Alerts: Wyoming health officials warn about rabies and West Nile virus as summer risks increase. CBD/Wellness Adjacent: A magnesium-food roundup and a CBD patch promo for menopausal aches both point to growing consumer interest in sleep and pain support.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.